These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7068286)

  • 21. [Absolute bioavailability of theophylline (Euphylline)].
    Somogyi A; Gugler R
    Fortschr Med; 1980 Nov; 98(43):1707-10. PubMed ID: 7450653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative blood level of dihydroergotoxine (DHET) after administration of two oral forms (solution & tablet): a preliminary study.
    Aliache JM; Briot M; Couquelet J; Vigo P
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):221-4. PubMed ID: 7308241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of bioavailability between nimotop and nimodipine tablet].
    Shi XJ; Wang HT; Wei Y; Zhang JH; Zhang LL; Zhong MK
    Yao Xue Xue Bao; 1997 Sep; 32(9):708-10. PubMed ID: 11596299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new formulation of fenofibrate: suprabioavailable tablets.
    Guichard JP; Blouquin P; Qing Y
    Curr Med Res Opin; 2000; 16(2):134-8. PubMed ID: 10893657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications.
    Kayitare E; Vervaet C; Ntawukulilyayo JD; Seminega B; Bortel V; Remon JP
    Int J Pharm; 2009 Mar; 370(1-2):41-6. PubMed ID: 19059324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
    Guivarc'h PH; Vachon MG; Fordyce D
    Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and relative bioavailability after single dose administration of 25 mg ketoprofen solution as compared to tablets.
    Stiegler S; Birkel M; Jost V; Lange R; Lücker PW; Wetzelsberger N
    Methods Find Exp Clin Pharmacol; 1995 Mar; 17(2):129-34. PubMed ID: 7674700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences.
    Jann MW; ZumBrunnen TL; Tenjarla SN; Ward ES; Weidler DJ
    Pharmacotherapy; 1998; 18(2):288-94. PubMed ID: 9545148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized clinical trial comparing doses and efficacy of lormetazepam tablets or oral solution for insomnia in a general practice setting.
    Ancolio C; Tardieu S; Soubrouillard C; Alquier C; Pradel V; Micallef J; Blin O
    Hum Psychopharmacol; 2004 Mar; 19(2):129-34. PubMed ID: 14994324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo evaluation of tablets and capsules containing spray-dried o/w-emulsions for oral delivery of poorly soluble drugs.
    Hansen T; Holm P; Rohde M; Schultz K
    Int J Pharm; 2005 Apr; 293(1-2):203-11. PubMed ID: 15778058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative bioavailability of iron from two different iron tablets used in the Indonesian Iron Supplementation Program.
    Thorand B; Pietzik K; Dillon D; Schultink W; Gross R
    Southeast Asian J Trop Med Public Health; 1993 Dec; 24(4):624-30. PubMed ID: 7939931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on formulation and bioavailability of benorilate tablets].
    Chen J; Tu XD
    Yao Xue Xue Bao; 1994; 29(9):707-12. PubMed ID: 7900541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption kinetics of dihydroergotoxine following oral administration to man.
    Woodcock BG; Rietbrock N; Loh W; Habedank WD
    Br J Clin Pharmacol; 1985 Dec; 20(6):603-9. PubMed ID: 4091992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of sirolimus tablet versus oral solution for prophylaxis of acute renal allograft rejection.
    Mathew TH; Van Buren C; Kahan BD; Butt K; Hariharan S; Zimmerman JJ
    J Clin Pharmacol; 2006 Jan; 46(1):76-87. PubMed ID: 16397287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral bioavailability of an L-5-HTP/carbidopa tablet].
    Obach R; Pruñonosa J; Vallés J; Vallés JM
    Arch Farmacol Toxicol; 1982 Dec; 8(3):179-82. PubMed ID: 6985117
    [No Abstract]   [Full Text] [Related]  

  • 40. Dihydroergotoxine kinetics in healthy men after intravenous and oral administration.
    Woodcock BG; Loh W; Habedank WD; Rietbrock N
    Clin Pharmacol Ther; 1982 Nov; 32(5):622-7. PubMed ID: 7128002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.